Atlas Trials

Stage IV Prostate Adenocarcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Prostate Adenocarcinoma

RecordFirmDate
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02844582)University of California, Davis2017-12-20
Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) (NCT03076203)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-09-22
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer (NCT03113617)Andrei Iagaru2017-04-10
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (NCT02601014)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-03-15
Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer (NCT02532114)University of Washington2015-12-31
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01503229)University of Washington2012-12-01

Track Stage IV Prostate Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.